The Effect of Mild and Moderate Hepatic Impairment on Pharmacokinetics, Pharmacodynamics, and Safety of Febuxostat, a Novel Nonpurine Selective Inhibitor of Xanthine Oxidase-Reference-Cited by-同舟云学术

The Effect of Mild and Moderate Hepatic Impairment on Pharmacokinetics, Pharmacodynamics, and Safety of Febuxostat, a Novel Nonpurine Selective Inhibitor of Xanthine Oxidase

Published:2006-01 Issue:1 Volume:46 Page:88-102
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Khosravan Reza,Grabowski Brian A.,Mayer Michael D.,Wu Jing-Tao,Joseph-Ridge Nancy,Vernillet Laurent

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference30 articles.

1. Incidence and risk factors for gout in white men;Roubenoff;JAMA,1991

2. The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988-1994;Kramer;Am J Kidney Dis,2002

3. Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population;Wallace;J Rheumatol,2004

4. Gout and risk of subsequent coronary heart disease: the Meharry-Hopkins Study;Gelber;Arch Intern Med,1997

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive Evaluation of OATP‐ and BCRP‐Mediated Drug–Drug Interactions of Methotrexate Using Physiologically‐Based Pharmacokinetic Modeling;Clinical Pharmacology & Therapeutics;2024-06-11

2. Gout Treatment and Clinical Considerations: The Role of Pegloticase, Colchicine, and Febuxostat;Cureus;2023-10-07

3. Progress in the Treatment of Hyperuricemia Using Integrated Traditional Chinese and Western Medicine;Advances in Clinical Medicine;2023

4. Population pharmacokinetic modelling of febuxostat in healthy subjects and people with gout;British Journal of Clinical Pharmacology;2022-07-28

5. Simultaneous determination of colchicine and febuxostat in rat plasma: Application in a rat pharmacokinetic study;Biomedical Chromatography;2020-07-24